Concepedia

R. Cartwright

RC

Statistics

Publications

3

Citations

351

H-Index

3

Active since

1998

Affiliations

Novartis (United States)(Current)

R. Cartwright is an author at Novartis (United States) specializing in medicine, pharmacology, and hill kinetics.

Publications per year

1998–2012

3

Publications

3

Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes

J. B. Kuemmerle‐Deschner, É. Hachulla, R. Cartwright et al. · Annals of the Rheumatic Diseases · 2011 · 217 citations

, , +12

Long-Term Efficacy and Safety Profile of Rilonacept in the Treatment of Cryopryin-Associated Periodic Syndromes: Results of a 72-Week Open-Label Extension Study

Hal M. Hoffman, M. Throne, Niran J. Amar et al. · Clinical Therapeutics · 2012 · 114 citations

, , +7

Three Distinct F-Actin Binding Sites in the <i>Dictyostelium</i> <i>discoideum</i> 34 000 Dalton Actin Bundling Protein

Rita W.L. Lim, Ruth Furukawa, Susan Eagle et al. · Biochemistry · 1998 · 20 citations

, , +17

1–3 of 3